Interaction of oxypertine with rat brain monoamine receptors.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology*; D002540:Cerebral Cortex / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D013134:Spiperone / Q000378:metabolism
D001679:Biogenic Amines; D007211:Indoles; D010879:Piperazines; D017981:Receptors, Neurotransmitter; D013134:Spiperone; D000262:Adenylyl Cyclases; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine